A carregar...
Publicação
O potencial colaborativo do farmacêutico comunitário na terapêutica do cancro da próstata
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 782.93 KB | Adobe PDF |
Orientador(es)
Resumo(s)
O cancro da próstata é o tipo de cancro mais frequente na população masculina. Nos últimos anos têm sido desenvolvidos novos compostos para o tratamento desta patologia, que apresentam grandes vantagens em termos de segurança e de eficácia.
O desenvolvimento destes compostos acompanhou o aumento da disponibilidade de antineoplásicos orais. Estes fármacos oferecem vantagens como a facilidade de administração, a comodidade para o doente e a redução de custos. As desvantagens incluem a redução de supervisão médica, erros de administração e biodisponibilidade imprevisível.
Como estes medicamentos são dispensados apenas no hospital e uma vez que o cancro é cada vez mais considerado uma doença crónica, a dispensa de antineoplásicos orais nas farmácias comunitárias tem de ser avaliada. Devido à sua proximidade com o doente, o farmacêutico comunitário poderá ter um papel muito importante na dispensa destes medicamentos, educando o doente ou o cuidador, de forma a garantir uma administração correta dos medicamentos e garantindo o uso seguro e eficaz dos antineoplásicos orais.
Prostate cancer is the most frequent type of cancer in the male population. In the past years, there has been developed new compounds for the treatment of this pathology that present great advantages in terms of safety and efficiency. The development of these compounds accompanied the increase in availability of oral antineoplastics. These drugs offer advantages as the ease of administration, commodity for the patient and cost reductions. The disadvantages include the reduction of medical supervision, administration errors and unpredictable bioavailability. As this drugs are only given at hospitals and since cancer is a chronic disease, the dispense of oral antineoplastics in community pharmacies should be evaluated. Due to his proximity with the patient, the community pharmacist could have a very important role on the dispensing of these drugs, educating the patient or his caregiver, to ensure correct administration of the medicines and ensuring the safe and effective use of oral antineoplastics.
Prostate cancer is the most frequent type of cancer in the male population. In the past years, there has been developed new compounds for the treatment of this pathology that present great advantages in terms of safety and efficiency. The development of these compounds accompanied the increase in availability of oral antineoplastics. These drugs offer advantages as the ease of administration, commodity for the patient and cost reductions. The disadvantages include the reduction of medical supervision, administration errors and unpredictable bioavailability. As this drugs are only given at hospitals and since cancer is a chronic disease, the dispense of oral antineoplastics in community pharmacies should be evaluated. Due to his proximity with the patient, the community pharmacist could have a very important role on the dispensing of these drugs, educating the patient or his caregiver, to ensure correct administration of the medicines and ensuring the safe and effective use of oral antineoplastics.
Descrição
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de Farmácia, 2017
Palavras-chave
Cancro da próstata Antineoplásicos orais Farmacêutico Comunitário Mestrado Integrado - 2017